Skip to main content

BRIEF RESEARCH REPORT article

Front. Public Health
Sec. Infectious Diseases: Epidemiology and Prevention
Volume 13 - 2025 | doi: 10.3389/fpubh.2025.1517213
This article is part of the Research Topic Challenges in reaching the UNAIDS 95-95-95 targets in Sub-Saharan Africa: Status, innovations, and pathways forward View all 3 articles

Differences in HIV infection trends in two regions of Cameroon with a longstanding HIV epidemic; insights from 2012 and 2022

Provisionally accepted
  • 1 Center of Research for Emerging and Re-Emerging Diseases / Institute of Medical Research and Medicinal Plants Studies (CREMER/IMPM), Yaounde, Cameroon
  • 2 National Institute of Cartography (INC), Ministry of Scientific Research and Innovation, Yaounde, Cameroon
  • 3 Programmes de Santé et Développement au Sein du Groupement de la Filière Bois du Cameroun (GFBC), Yaounde, Cameroon
  • 4 Faculty of Medecine and Biomedical Sciences, University of Yaounde 1, Yaounde, Centre, Cameroon
  • 5 HIV Pathogenesis Programme, University of KwaZulu-Natal, Durban, South Africa

The final, formatted version of the article will be published soon.

    Introduction: To achieve the UNAIDS 95-95-95 target by 2025, it is of great importance to test and diagnose individuals infected with HIV; especially those residing in communities with limited access to health and in areas with a longstanding HIV epidemic, where the virus has been circulating since the early phase of the pandemic. In this regard, we determined the HIV prevalence in remote communities of the East and South administrative regions of Cameroon where the four cross-species SIV transmissions that gave rise to the four HIV-1 groups likely happened. Methods: We did this in two different periods: 2012/2013 (Period 1; 4435 participants enrolled in the East and 2347 in the South) and 2021/2022 (Period 2; 2203 participant enrolled in the East and 2347 in the South) using HIV1/2 rapid assays and standard ELISAs and according to the WHO testing strategy. Results: During Period 1, the HIV seroprevalence in the East was 6.9%. This prevalence had significantly decreased to 2.7% [Prevalence Difference or PD: 4.1 (3.1; 5.2); p<0.001] by Period 2. Contrasting with these results, the HIV prevalence in the South during Period 1 was 5.5% and did not significantly change by Period 2 at 5.2% [PD: 0.3 (1.07;1.6); p=0.67]. Conclusion: Our data suggest that HIV transmission in remote communities of the South administrative region of Cameroon has likely remained uncurbed over the past decade. As a result, this region should be prioritized in efforts to curb the spread of HIV and reduce its prevalence.

    Keywords: HIV prevalence, Cameroon, HIV diagnosis, HIV diversity, HIV infection

    Received: 25 Oct 2024; Accepted: 30 Jan 2025.

    Copyright: © 2025 Ngoume, Teagho, Eselacha, Goni, Kenfack, Tchakoute, Nguefack-Tsague and Tongo. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence:
    Georges Nguefack-Tsague, Faculty of Medecine and Biomedical Sciences, University of Yaounde 1, Yaounde, Centre, Cameroon
    Marcel Tongo, Center of Research for Emerging and Re-Emerging Diseases / Institute of Medical Research and Medicinal Plants Studies (CREMER/IMPM), Yaounde, Cameroon

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.